Latest Regulatory Approvals News

Rhythm Biosciences has regained NATA accreditation for its geneType laboratory, a key step toward commercialising its ColoSTAT® cancer risk test as an in-house diagnostic.

Capricorn Metals has extended its mining contract with MACA Ltd for Karlawinda and named MACA preferred contractor for Mt Gibson, locking in cost certainty and supporting production growth.

Amplia Therapeutics has secured US ethics approval to launch a Phase 2 trial combining its drug narmafotinib with FOLFIRINOX chemotherapy for advanced pancreatic cancer, marking a key step in its clinical development.

Garda Property Group has announced a quarterly distribution of AUD 0.018 per security, combining an ordinary and a special fully franked dividend, reflecting strong capital outcomes from FY24.

Microba Life Sciences announces a $12.5 million equity raise, including a strategic $8.3 million investment from Sonic Healthcare, aiming to fuel growth in the UK and achieve regional break-even by FY26.

Alligator Energy has raised A$17.25 million through a strongly supported placement to institutional investors, positioning the company to advance key development stages at its Samphire Uranium Project. The funds will underpin exploration, feasibility studies, and the upcoming Field Recovery Trial.

Larvotto Resources has secured preliminary regulatory approval to extend mining at its Hillgrove Gold-Antimony Mine through 2026, paving the way for project financing and production ramp-up.

PointsBet Holdings Limited updates shareholders on competing takeover bids, endorsing MIXI’s $1.20 cash offer while highlighting significant uncertainties and lower value in Betr Entertainment’s all-scrip proposal.

Prominence Energy has agreed to acquire a vast natural hydrogen and helium exploration portfolio on the Gawler Craton, backed by a $1.75 million capital raise and strategic board appointments.

Envirosuite has secured a key regulatory green light from FIRB for its acquisition by Ideagen, moving the proposed Scheme of Arrangement closer to shareholder approval.

Optiscan Imaging Ltd has entered a five-year exclusive collaboration with Long Grove Pharmaceuticals to jointly develop new clinical applications for the fluorescein drug AK-FLOUR®, supporting US clinical trials and FDA regulatory submissions for Optiscan’s InVue® surgical device.

Magnetic Resources NL has announced a significant 22% increase in the Lady Julie Gold Project resource, now totaling 2.14 million ounces, boosting the overall Laverton region resource to 2.32 million ounces. This upgrade reflects enhanced confidence in mineral continuity and advances the project closer to development.